 Chongqing Pharscin Pharmaceutical Co., LTD.(stock abbreviation: Pharscin Pharma, stock code: 002907)is a key nationalhigh-tech enterprise with anintegration of the research and development,production and sales of drugs. Its headquarter and research center are based inLiangjiang new area of Chongqing city and its production center is located inRongchang High-tech Zone, Chongqing. Pharscin Pharma owns Chongqing Pharscin Medicine Co.,LTD., Chongqing Pharscin Pharmacy Retail Chain Co., Ltd. and Chongqing PharscinBiotech Co., LTD. Guided by the technology-led andinnovation-driven principle, Pharscin Pharma stays committed to manufacturinghigh quality products with special, sophisticated, unique and innovativefeatures.At present, it has 68 drug varieties, includingChinese patent medicine, APIs and finished pharmaceutical products. Among them49 drugs are in the catalog of National Medical Insurance, 46 drugs havedomestic patents and one has international patent. Pharscin Pharma has undertaken national,provincial and ministerial scientific and technological research anddevelopment projects as many as 98, including the National "EleventhFive-Year" Major New Drug Development, the National "Twelfth Five-Year"Major New Drug Development, the National 863 High-Tech Plan, the National TorchPlan and among others, giving all it has to better human life and health. Pharscin Pharma attaches great importance toscientific and technological innovation and has built a strong innovativeplatform for the transformation of scientific and technological achievements.It has successfully applied the key technologies such as extraction ofthermosensitive active ingredients of traditional Chinese medicine, automatictransmission of powders and production control of soft capsules intomanufacturing. The company is now in the process of building an automatedinformation management system, purposely realizing the informative,internet-based, digital and intelligent management of production through theautomated module control in every link of production. Pharscin Pharma has built 11 domesticallyleading production lines, including tablets, powders, granules, hard and softcapsules, powder for injection, freeze-dried powder injection, small-volumeinjection, API syntheses and botanical drug extraction, etc.Thecompany's manufactured products in the finished products inspection, samplinginspection by Food and Drug Administration, national evaluation samplinginspection and market sampling inspection have always been 100% qualified.It has won the honorarytitles of the "Excellent Quality Management Team in the PharmaceuticalIndustry in China", the "National Excellent Quality ManagementTeam" and the "Safe and Reliable Medicines" published by theMinistry of Health. It enjoys a high reputation among consumers and medicalworkers. Pharscin Pharma stays committed to academicpromotion and has built its own marketing team to deliver the advanced,accurate and up-to-date information and services to medical workers.Themarketing network covers 31 provinces, cities and autonomous regions and isestablishing its presence in overseas markets. Employment-wise, the Pharscin Pharma alwaysplaces people first and respects talents. The company now has 1000 staffmembers, with 11% of senior professionals like the staff with the PhD degreeand master's degree, professors, associate professors, researchers, seniorengineers, 38% of intermediate professionals, and more than 80% ofprofessionals with junior college degrees. This talent pool has put thelong-term growth of the company on a firmer footing. Pharscin Pharma takes "rejuvenating national pharmaceutical, manufacturing quality medicine, safeguarding for health ," as its company mission, it upholds "honesty, diligence, gratitude, studying, teamwork and innovation” as the company value, and are striving for the goal of "building a first-class domestic enterprise and promoting the development of human health cause" in a steady pace. 
You Hongtao Chairman of Pharscin Pharma You Hongtao is the chairman of Pharscin Pharma with a master degree in medicine, a professor-level senior engineer, a representative of Chongqing Municipal People's Congress and a state council expert for special allowance. Prior to the founding of Pharscin Pharma in 1996, he worked as a deputy dean and associate professor in the Affiliated Hospital of Luzhou Medical College. He was a well-known orthopedic surgeon locally and a hands-on professional with more than 30 years of experience in the pharmaceutical industry. With the focus on overall strategic management and his profound and unique understanding of the industry, he was able to predict the industry development trend. As early as 20 years ago, he advocated the adoption of academic promotion and self-built marketing team to put the company's long-term growth on a firmer footing. At present, he is the vice president of China Pharmaceutical Material Association, the vice director of the Special Committee of Drug Clinical Evaluation and Research of China Association of Chinese Medicine, and the executive president of Chongqing Pharmaceutical Profession Association.  Liu Xiaoying General Manager and Board Director of Pharscin Pharma Liu Xiaoying is the general manager and a board director of Pharscin Pharma with a
master degree in pharmacy from Nanjing University of Chinese Medicine. She is
also an associate professor, a licensed pharmacist, a state council expert for
special allowance and a member of Chongqing CPPCC. Before
joining to the Pharscin Pharma in 1999, she worked for medicine research and
development and has accumulated more than 30 years of rich experience in the
research and development, registration and approval and management of drugs in
China. She is currently the vice president of China Chemical Pharmaceutical Industry Association, the deputy director of the Chinese
Medicine Quality and Safety Professional Committee, the vice chairman of the
China Association of Traditional Chinese Medicine for Encephalopathy Research,
the vice president of the Chongqing Medical Insurance Research Association, and
a member of the expert group review team of the Chongqing Science and
Technology Commission, a member of the review team of the New Drug Evaluation
Expert Group of Chongqing Food and Drug Administration and a member of the
China Medical Information Expert Review Committee. Wang Ying Deputy General Manager and Board Director of Pharscin Pharma Wang Ying is an associate professor and the
deputy general manager of the Pharscin Pharma. She
has been engaged in medical clinical work for 15 years with strong medical
theory, rich clinical experience and professional teaching skills. As she was once the deputy chief physician of the
Department of Gastroenterology at the Affiliated Hospital of Medical College, she
has a thorough understanding of the needs of the prescription market. After joining the Pharscin Pharma in 1998, she has
started to work as the manager of marketing department and deputy general
manager of the company and has built the sales team, the sales department of
internal affairs, the bidding office and the marketing department. He set up a
scientific marketing management system with Pharscin Pharma features, a
systematic management procedure of drug bidding procurement and a product
bidding information database. Hang Yonglu Deputy General Manager and Board Directorof the Pharscin Pharma Hang Yonglu, the deputy general manager and Board Director of Pharscin Pharma. He has been engaged in pharmaceutical manufacturing for more than 40 years, and is a GMP review expert of Chongqing Food and Drug Administration. He organized more than 20 GMP on-site certifications, technical transfer verification of multiple drug projects, and built the quality management system of drug productions. He joined Pharscin Pharma in 2001 and is familiar with the process design of production lines of various preparations, equipment selection and installation, production organization, quality, safety, measurement, energy, special equipment, environmental protection and management. He is proficient in GMP hardware and software certification, on-site inspection, management and among others. From 2002 to 2017, under his leadership, Pharscin Pharma passed all GMP certifications smoothly, from the old-version GMP to the new version. |